Uterine artery embolisation (UAE) is a minimally invasive medical procedure used primarily to treat uterine fibroids—noncancerous growths in the uterus that can cause significant symptoms such as heavy menstrual bleeding, pelvic pain, and pressure. UAE offers an alternative to traditional surgical treatments like hysterectomy or myomectomy, preserving the uterus and often allowing for quicker recovery. This procedure has gained importance due to its effectiveness, safety profile, and fertility-preserving potential, making it a valuable option for women seeking symptom relief without major surgery.
Understanding the anatomy of the uterus and its blood supply is essential to grasp how UAE works. The uterus is a muscular organ located in the female pelvis, primarily supplied by the uterine arteries, which branch off from the internal iliac arteries. These arteries provide oxygenated blood to the uterine tissue, including any fibroids present.
Uterine fibroids (also called leiomyomas) are benign smooth muscle tumors that develop within the uterine wall. They vary in size, number, and location (submucosal, intramural, or subserosal), and their growth depends on hormonal influences, particularly estrogen and progesterone. Because fibroids are highly vascular, cutting off their blood supply can cause them to shrink and symptoms to improve.
The exact cause of uterine fibroids is not fully understood, but several risk factors and contributing factors have been identified:
UAE targets the fibroids by blocking the uterine arteries that supply them, leading to ischemia and shrinkage.
Many women with fibroids are asymptomatic, but when symptoms occur, they can include:
Diagnosis of uterine fibroids and assessment for UAE involves:
A multidisciplinary approach involving gynecologists and interventional radiologists is essential for planning UAE.
Treatment depends on symptom severity, fibroid characteristics, patient age, fertility desires, and overall health.
UAE is a minimally invasive alternative that blocks blood flow to fibroids, causing them to shrink and symptoms to improve, while preserving the uterus.
UAE is performed by an interventional radiologist under local anesthesia with sedation:
The procedure typically lasts 1-2 hours, and patients may stay in the hospital overnight for observation.
Hospital stay: Usually 24 hours for monitoring pain and complications.
UAE is generally safe but carries some risks:
Most women experience significant symptom relief and fibroid shrinkage after UAE. Studies show:
Fertility outcomes after UAE are still under study; women desiring pregnancy should discuss options carefully.
Seek medical attention if you experience:
Early consultation with a gynecologist can facilitate timely diagnosis and treatment.
Uterine Artery Embolisation is a valuable, minimally invasive treatment option for women suffering from symptomatic uterine fibroids. By understanding the anatomy, causes, symptoms, diagnosis, and treatment options, patients can make informed decisions in collaboration with their healthcare providers. UAE offers effective symptom relief with uterus preservation and faster recovery compared to traditional surgery. However, like all medical procedures, it carries risks and requires appropriate patient selection and follow-up. If you experience symptoms suggestive of uterine fibroids, consult a healthcare professional to explore the best treatment tailored to your needs.
Aenean porta orci nam commodo felis hac ridiculus fusce fames maximus erat sed dictumst blandit arcu suspendisse sollicitudin luctus in nec